Cancer Epidemiology Biomarkers & Prevention · 2007 · 169 citations · 21 references
MedicineOncologyCancer EpidemiologyEpidemiologic MethodsEpidemiologyCancer IncidenceCancer MortalityCancer RiskMalignant NeoplasmsParkinson DiseaseTobacco-related Cancer EpidemiologyCancer Incidence EpidemiologyCancer Risk EstimationIncident DiagnosisLifetime Cancer RiskLung Cancer RiskMatched Cohort AnalysisProspective Cohort DataTobacco-related Cancer Risk
BACKGROUND: Prior studies suggest a decreased risk of cancer among patients with Parkinson's disease (PD). METHODS: Matched cohort analysis among the 22,071 participants in the Physician's Health Study. A total of 487 incident cases of PD without preceding cancer were identified by self-report. Each PD case was matched by age to a reference participant who was alive and cancer free at the time of PD diagnosis. Both cohorts were followed for incident cancer. We used proportional hazards models to calculate adjusted relative risks (RR) for cancer. RESULTS: A total of 121 cancers were confirmed during a median follow-up of 5.2 years (PD) and 5.9 years (reference). Those with PD developed less cancer (11.0% versus 14.0%), with an adjusted RR of 0.85 [95% confidence interval (95% CI), 0.59-1.22]. Reduced risk was present for smoking-related cancers such as lung (RR, 0.32), colorectal (RR, 0.54), and bladder (RR, 0.68), as well as for most non-smoking-related cancers such as prostate cancer (RR, 0.74). In contrast, PD patients were at significantly increased risk (RR, 6.15; 95% CI, 1.77-21.37) for melanoma. PD patients who smoked were at reduced risk for smoking-related cancer (RR, 0.33; 95% CI, 0.12-0.92), whereas nonsmokers with PD were at increased risk (RR, 1.80; 95% CI, 0.60-5.39). This interaction was statistically significant (P(interaction) = 0.02). CONCLUSIONS: Our results suggest a decreased incidence of most cancers in patients with PD. PD patients had a significantly increased risk of malignant melanoma, a finding consistent with prior studies. We confirmed an interaction between smoking and the relationship of PD to smoking-related cancer that may fit the pattern of a gene-environment interaction.
21
Charles H. Hennekens, Julie E. Buring, JoAnn E. Manson et al. · New England Journal of Medicine · 1996 · 2.4K citations · Full text
Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease
Colin Smith, C. Roland Wolf, A C Gough et al. · The Lancet · 1992 · 421 citations
Life Sciences, Genetics, Neurology +12
Physical activity and the risk of Parkinson disease
Honglei Chen, S. M. Zhang, M. A. Schwarzschild et al. · Neurology · 2005 · 372 citations
Catherine M. Roe, María Isabel Behrens, Chengjie Xiong et al. · Neurology · 2005 · 230 citations